Fundraising FoxPurigen Biosystems, Inc.
Pleasanton, US · Founded 2012 · Delaware corporation · 3 known investors
Find your way into Purigen Biosystems, Inc.
Sign up to see every warm intro you have to Purigen Biosystems, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Purigen Biosystems, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Technologies for extracting, enriching, and quantifying nucleic acids (acquired).
Founders & leadership
Purigen Biosystems, Inc. was founded in 2012 by Bill W. Colston, Ph.D., Klint Rose, Ph.D., Juan G. Santiago, Klint Rose, and Amy Hiddessen.
Board
Investors · 3
How we know: Cota Capital's portfolio page · funding news · marketscreener.com · Not right? Tell us
How we know: board seat on SEC Form D · funding news · marketscreener.com · Not right? Tell us
How we know: funding news · marketscreener.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$61.1M disclosed across 3 rounds · 2014–2019
▶$34.4MraisedApr 2021 · 16 investors · BiotechnologyRule 506(b)
- Barney E. Saunders,Ph.D.Executive Officer, Director
- Steve ReichenbachExecutive Officer
- Bill W. Colston, Ph.D.Director
- Mira Chaurushiya, Ph.D.Director
- Kevin CorcoranDirector
- Klint Rose, Ph.D.Executive Officer
- Joseph J. VictorDirector
- Offering amount
- $34.4M
- Amount sold
- $34.4M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.4MraisedJun 2018 · 28 investors · BiotechnologyRule 506(b)
- Barnett SaundersExecutive Officer, Director
- Joseph VictorDirector
- Mitchell MutzDirector
- Klint RoseExecutive Officer, Promoter
- Steve ReichenbachExecutive Officer
- Andrew SchwabDirector
- Juan SantiagoPromoter
- Bill W. ColstonDirector
- Offering amount
- $30.8M
- Amount sold
- $26.4M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
- Juan G. SantiagoExecutive Officer, Director, Promoter
- Klint RoseExecutive Officer, Director, Promoter
- Amy HiddessenExecutive Officer, Director, Promoter
- Offering amount
- $1.7M
- Amount sold
- $200K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Purigen Biosystems, Inc. do?
- Technologies for extracting, enriching, and quantifying nucleic acids (acquired).
- Who founded Purigen Biosystems, Inc.?
- Purigen Biosystems, Inc. was founded by Bill W. Colston, Ph.D., Klint Rose, Ph.D., Juan G. Santiago, Klint Rose, Amy Hiddessen in 2012.
- Who are Purigen Biosystems, Inc.'s investors?
- Purigen Biosystems, Inc.'s investors include Cota Capital, 5AM Ventures, Roche Venture Fund.
- How much funding has Purigen Biosystems, Inc. raised?
- Purigen Biosystems, Inc. has disclosed $61.1M raised across 3 rounds.
- Where is Purigen Biosystems, Inc. headquartered?
- Purigen Biosystems, Inc. is headquartered in Pleasanton, US.